Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;36(10):972-9.
doi: 10.1111/apt.12059. Epub 2012 Sep 25.

The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin

Affiliations

The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin

E A Marcus et al. Aliment Pharmacol Ther. 2012 Nov.

Abstract

Background: Penicillins inhibit cell wall synthesis; therefore, Helicobacter pylori must be dividing for this class of antibiotics to be effective in eradication therapy. Identifying growth responses to varying medium pH may allow design of more effective treatment regimens.

Aim: To determine the effects of acidity on bacterial growth and the bactericidal efficacy of ampicillin.

Methods: H. pylori were incubated in dialysis chambers suspended in 1.5-L of media at various pHs with 5 mM urea, with or without ampicillin, for 4, 8 or 16 h, thus mimicking unbuffered gastric juice. Changes in gene expression, viability and survival were determined.

Results: At pH 3.0, but not at pH 4.5 or 7.4, there was decreased expression of ~400 genes, including many cell envelope biosynthesis, cell division and penicillin-binding protein genes. Ampicillin was bactericidal at pH 4.5 and 7.4, but not at pH 3.0.

Conclusions: Ampicillin is bactericidal at pH 4.5 and 7.4, but not at pH 3.0, due to decreased expression of cell envelope and division genes with loss of cell division at pH 3.0. Therefore, at pH 3.0, the likely pH at the gastric surface, the bacteria are nondividing and persist with ampicillin treatment. A more effective inhibitor of acid secretion that maintains gastric pH near neutrality for 24 h/day should enhance the efficacy of amoxicillin, improving triple therapy and likely even allowing dual amoxicillin-based therapy for H. pylori eradication.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Box-whisker plots representing changes in mRNA from transcriptomal analysis. H. pylori were incubated for 4 hours at pH 3.0 and 7.4 in the presence of 5mM urea. At pH 3.0, there was a decrease in mRNA levels of cell wall biosynthesis (HP0159), cell division (HP0748, HP0749, HP1560), and penicillin binding (HP1565) genes. These data suggest that, at pH 3.0, the organisms are non-replicative, not synthesizing cell wall proteins, and have a reduced metabolism, rendering the bacteria ampicillin insensitive at pH 3.0.
Figure 2
Figure 2
H. pylori viability by the live/dead assay method in the absence or presence of ampicillin at neutral and acidic pH. H. pylori incubated for 8 (A) and 16 (B) hours at pH 3.0 in the absence of ampicillin were less viable then at pH 4.5 and 7.4. Ampicillin significantly decreased the viability of the bacteria at both pH 4.5 and 7.4 but had no effect at pH 3.0 at both incubation times.
Figure 3
Figure 3
H. pylori survival in the presence of ampicillin at neutral and acidic pH. After 8 hour exposure to acidity, there was no change in the number of CFUs at pH 4.5 or 7.4, and a marked decline with exposure to ampicillin at these pH levels, but no change with ampicillin at pH 3.0 (A). Similar data were obtained after 16 hour incubation (B).

Similar articles

Cited by

References

    1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002 Oct 10;347(15):1175–86. - PubMed
    1. Blaser MJ. Helicobacter pylori: its role in disease. Clin Infect Dis. 1992 Sep;15(3):386–91. - PubMed
    1. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991 Oct 17;325(16):1132–6. - PubMed
    1. Parsonnet J. Gastric adenocarcinoma and Helicobacter pylori infection. West J Med. 1994 Jul;161(1):60. - PMC - PubMed
    1. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991 Oct 17;325(16):1127–31. - PubMed

Publication types

MeSH terms